Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIAT: 2010-2012

Historic EBIAT for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$1.9 million.

  • Sonoma Pharmaceuticals' EBIAT rose 24.93% to -$1.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.8 million, marking a year-over-year increase of 34.47%. This contributed to the annual value of -$7.3 million for FY2012, which is 7.79% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' EBIAT stood at -$1.9 million, which was down 25.87% from -$1.5 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' EBIAT registered a high of $445,000 during Q2 2012, and its lowest value of -$2.5 million during Q4 2011.
  • In the last 3 years, Sonoma Pharmaceuticals' EBIAT had a median value of -$1.8 million in 2012 and averaged -$1.7 million.
  • Data for Sonoma Pharmaceuticals' EBIAT shows a peak YoY increase of 120.46% (in 2012) and a maximum YoY decrease of 81.05% (in 2012) over the last 5 years.
  • Over the past 3 years, Sonoma Pharmaceuticals' EBIAT (Quarterly) stood at -$2.2 million in 2010, then dropped by 14.22% to -$2.5 million in 2011, then rose by 24.93% to -$1.9 million in 2012.
  • Its EBIAT stands at -$1.9 million for Q4 2012, versus -$1.5 million for Q3 2012 and $445,000 for Q2 2012.